Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database.
Catherine Weil-OlivierMuhamed-Kkeir TahaCorinne EmeryStéphane BouéeEkkehard BeckEmmanuel ArisVéronique Loncle-ProvotGaëlle NachbaurCeline PribilPublished in: Infectious diseases and therapy (2021)
The economic burden of IMD in France is high and, over the long-term, is driven by sequelae management.